부산대학교 도서관

Sandoval, Philip; Chuang, Bei-Ching; Cohen, Lawrence; Yoneyama, Tomoki; Pusalkar, Sandeepraj ; Yucha, Robert W.; Chowdhury, Swapan K ; Chothe, Paresh P.

In Drug Metabolism and Disposition July 2022 50(7):980-988

Yin W; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA.; Ballard TE; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA.; Zhu SX; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA.; Hsiao S; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA.; Chen H; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA.; Li Y; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA.; Chowdhury SK; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA.; Stevenson A; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA.; Hui T; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA.; Hunt A; Celerion, Lincoln, Nebraska, USA.; Asgharnejad M; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA.; Han S; Takeda Development Center Americas, Inc, Cambridge, Massachusetts, USA.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE

Sandoval P; Global Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc. (TDCA), 95 Hayden Avenue, Lexington, Massachusetts, 02421, USA.; Chuang BC; Global Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc. (TDCA), 95 Hayden Avenue, Lexington, Massachusetts, 02421, USA.; Fallon JK; Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Smith PC; Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Chowdhury SK; Boston Pharmaceuticals, 55 Cambridge Parkway, Suite 400, Cambridge, Massachusetts, 02142, USA.; Griffin RJ; Global Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc. (TDCA), 95 Hayden Avenue, Lexington, Massachusetts, 02421, USA.; Xia CQ; ReNAgade Therapeutics Management Co., 450 Kendall Street, Cambridge, Massachusetts, 02142, USA.; Iwasaki S; Drug Metabolism and Pharmacokinetics Research Laboratories, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-Chrome, Fujisawa, Kanagawa, 251-8555, Japan.; Chothe PP; Global Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc. (TDCA), 95 Hayden Avenue, Lexington, Massachusetts, 02421, USA. pareshchothe@yahoo.com.

Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

Chen H; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.).; Shah A; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.).; Kato S; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.).; Griffin R; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.).; Zhang S; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.).; Pusalkar S; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.).; Cohen L; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.).; Li Y; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.).; Chowdhury SK; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.).; Zhu SX; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (H.C., A.S., S.K., R.G., S.P., L.C., Y.L., S.K.C., S.X.Z.); and Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc., Cambridge, Massachusetts (S.Z.) xiaochun.zhu@takeda.com.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9421550 Publication Model: Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE

Ma, Shuguang; Chowdhury, Swapan K

Bioanalysis. Mar 01, 2014 6(5):587-590

Ma, Shuguang; Chowdhury, Swapan K

Bioanalysis. May 01, 2013 5(10):1285-1297

Ma, Shuguang; Chowdhury, Swapan K

Bioanalysis. Mar 01, 2012 4(5):501-510

Zhou X; Quantitative Clinical Pharmacology, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. xiaofei.zhou@takeda.com.; Pusalkar S; Quantitative Clinical Pharmacology, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.; Chowdhury SK; Quantitative Clinical Pharmacology, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.; Searle S; PRA Health Sciences, Salt Lake City, UT, USA.; Li Y; Quantitative Clinical Pharmacology, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.; Ullmann CD; MaxCyte, Inc., Gaithersburg, MD, USA.; Venkatakrishnan K; Quantitative Clinical Pharmacology, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.

Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

Bolleddula J; Takeda Development Center Americas, Inc., Lexington, Massachusetts swapan@bostonpharmaceuticals.com bolleddulajp@yahoo.com.; Chen H; Takeda Development Center Americas, Inc., Lexington, Massachusetts.; Cohen L; Takeda Development Center Americas, Inc., Lexington, Massachusetts.; Zhou X; Takeda Development Center Americas, Inc., Lexington, Massachusetts.; Pusalkar S; Takeda Development Center Americas, Inc., Lexington, Massachusetts.; Berger A; Takeda Development Center Americas, Inc., Lexington, Massachusetts.; Sedarati F; Takeda Development Center Americas, Inc., Lexington, Massachusetts.; Venkatakrishnan K; Takeda Development Center Americas, Inc., Lexington, Massachusetts.; Chowdhury SK; Takeda Development Center Americas, Inc., Lexington, Massachusetts swapan@bostonpharmaceuticals.com bolleddulajp@yahoo.com.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE

Pusalkar S; Global; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., 35 Landsdowne Street, Cambridge, MA, 02139, USA.; Servier Pharmaceuticals, Cambridge, MA, USA.; Chowdhury SK; Global; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., 35 Landsdowne Street, Cambridge, MA, 02139, USA.; Boston Pharmaceuticals, Cambridge, MA, USA.; Czerniak R; Global; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., 35 Landsdowne Street, Cambridge, MA, 02139, USA.; Zhu X; Global; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., 35 Landsdowne Street, Cambridge, MA, 02139, USA.; Li Y; Global; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., 35 Landsdowne Street, Cambridge, MA, 02139, USA.; Balani SK; Global; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., 35 Landsdowne Street, Cambridge, MA, 02139, USA.; Ramsden D; Global; Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc., 35 Landsdowne Street, Cambridge, MA, 02139, USA. diane.ramsden@astrazeneca.com.; AstraZeneca, Waltham, MA, USA. diane.ramsden@astrazeneca.com.

Publisher: Springer France Country of Publication: France NLM ID: 7608491 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2107-0180 (Electronic) Linking ISSN: 03787966 NLM ISO Abbreviation: Eur J Drug Metab Pharmacokinet Subsets: MEDLINE

Guo Y; Drug Metabolism and Pharmacokinetics, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.; Shah A; Drug Metabolism and Pharmacokinetics, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.; Oh E; Drug Metabolism and Pharmacokinetics, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.; Chowdhury SK; Drug Metabolism and Pharmacokinetics, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.; Zhu X; Drug Metabolism and Pharmacokinetics, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts xiaochun.zhu@takeda.com.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE

Wolenski FS; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA.; Zhu AZX; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA.; Johnson M; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA.; Yu S; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA.; Moriya Y; Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan.; Ebihara T; Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan.; Csizmadia V; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA.; Grieves J; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA.; Paton M; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA.; Liao M; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA.; Gemski C; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA.; Pan L; Takeda Pharmaceuticals International Co, Deerfield, Illinois, USA.; Vakilynejad M; Takeda Pharmaceuticals International Co, Deerfield, Illinois, USA.; Dragan YP; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA.; Chowdhury SK; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA.; Kirby PJ; Takeda Pharmaceuticals International Co, Cambridge, Massachusetts, USA.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 9805461 Publication Model: Print Cited Medium: Internet ISSN: 1096-0929 (Electronic) Linking ISSN: 10960929 NLM ISO Abbreviation: Toxicol Sci Subsets: MEDLINE

Bolleddula J; Drug Metabolism and Pharmacokinetics Department (J.B., A.S., M.S., A.K., S.K.C.) and Oncology Drug Discovery Unit (M.D.S.), Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts Jayaprakasam.bolleddula@agios.com.; Shah A; Drug Metabolism and Pharmacokinetics Department (J.B., A.S., M.S., A.K., S.K.C.) and Oncology Drug Discovery Unit (M.D.S.), Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.; Shadid M; Drug Metabolism and Pharmacokinetics Department (J.B., A.S., M.S., A.K., S.K.C.) and Oncology Drug Discovery Unit (M.D.S.), Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.; Kamali A; Drug Metabolism and Pharmacokinetics Department (J.B., A.S., M.S., A.K., S.K.C.) and Oncology Drug Discovery Unit (M.D.S.), Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.; Smith MD; Drug Metabolism and Pharmacokinetics Department (J.B., A.S., M.S., A.K., S.K.C.) and Oncology Drug Discovery Unit (M.D.S.), Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.; Chowdhury SK; Drug Metabolism and Pharmacokinetics Department (J.B., A.S., M.S., A.K., S.K.C.) and Oncology Drug Discovery Unit (M.D.S.), Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE

Bolleddula J; a Department of Drug Metabolism and Pharmacokinetics , Takeda Pharmaceuticals International Co. , Cambridge , MA , USA.; Chowdhury SK; a Department of Drug Metabolism and Pharmacokinetics , Takeda Pharmaceuticals International Co. , Cambridge , MA , USA.

Publisher: Informa Healthcare Country of Publication: England NLM ID: 0322067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-9883 (Electronic) Linking ISSN: 03602532 NLM ISO Abbreviation: Drug Metab Rev Subsets: MEDLINE

Pusalkar S; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Tokyo, Japan sandeepraj.pusalkar@takeda.com.; Zhou X; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Tokyo, Japan.; Li Y; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Tokyo, Japan.; Cohen L; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Tokyo, Japan.; Yang JJ; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Tokyo, Japan.; Balani SK; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Tokyo, Japan.; Xia C; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Tokyo, Japan.; Shyu WC; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Tokyo, Japan.; Lu C; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Tokyo, Japan.; Venkatakrishnan K; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Tokyo, Japan.; Chowdhury SK; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Tokyo, Japan.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE

Bajaj P; Drug Safety Research and Evaluation (P.B.) and Drug Metabolism and Pharmacokinetics Department (S.K.C., R.Y., G.X.), Takeda Pharmaceutical International Co., Cambridge, Massachusetts; and Department of Pharmaceutics, University of Washington, Seattle, Washington (E.J.K.) Piyush.Bajaj@takeda.com.; Chowdhury SK; Drug Safety Research and Evaluation (P.B.) and Drug Metabolism and Pharmacokinetics Department (S.K.C., R.Y., G.X.), Takeda Pharmaceutical International Co., Cambridge, Massachusetts; and Department of Pharmaceutics, University of Washington, Seattle, Washington (E.J.K.).; Yucha R; Drug Safety Research and Evaluation (P.B.) and Drug Metabolism and Pharmacokinetics Department (S.K.C., R.Y., G.X.), Takeda Pharmaceutical International Co., Cambridge, Massachusetts; and Department of Pharmaceutics, University of Washington, Seattle, Washington (E.J.K.).; Kelly EJ; Drug Safety Research and Evaluation (P.B.) and Drug Metabolism and Pharmacokinetics Department (S.K.C., R.Y., G.X.), Takeda Pharmaceutical International Co., Cambridge, Massachusetts; and Department of Pharmaceutics, University of Washington, Seattle, Washington (E.J.K.).; Xiao G; Drug Safety Research and Evaluation (P.B.) and Drug Metabolism and Pharmacokinetics Department (S.K.C., R.Y., G.X.), Takeda Pharmaceutical International Co., Cambridge, Massachusetts; and Department of Pharmaceutics, University of Washington, Seattle, Washington (E.J.K.).

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE

Schadt S; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.) simone.schadt@roche.com.; Bister B; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.).; Chowdhury SK; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.).; Funk C; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.).; Hop CECA; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.).; Humphreys WG; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.).; Igarashi F; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.).; James AD; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.).; Kagan M; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.).; Khojasteh SC; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.).; Nedderman ANR; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.).; Prakash C; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.).; Runge F; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.).; Scheible H; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.).; Spracklin DK; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.).; Swart P; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.).; Tse S; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.).; Yuan J; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.).; Obach RS; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland (S.S., C.F.); Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d. Riß, Germany (B.B., F.R.); Drug Metabolism and Pharmacokinetics Department, Takeda Pharmaceutical International Co., Cambridge, Massachusetts (S.K.C., J.Y.); Genentech, Inc., Drug Metabolism and Pharmacokinetics, South San Francisco, California (C.E.C.A.H., S.C.K.); Bristol-Myers Squibb Pharmaceutical Co., Princeton, New Jersey (W.G.H.); Research Division, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan (F.I.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, Basel, Switzerland (A.D.J.); PK Sciences (ADME), Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey (M.K.); Unilabs York Bioanalytical Solutions, Discovery Park House, Discovery Park, Sandwich, Kent, United Kingdom (A.N.R.N); Drug Metabolism, Pharmacokinetics and Clinical Pharmacology, Agios, Cambridge, Massachusetts (C.P.); Merck Biopharma, Quantitative Pharmacology and Drug Disposition, NCE Drug Disposition, Darmstadt, Germany (H.S., P.S.); and Pfizer, Pharmacokinetics, Dynamics and Metabolism, Groton, Connecticut (D.K.S., S.T., R.S.O.).

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE

Ma S; Department of Drug Metabolism & Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.; Chowdhury SK; Department of Drug Metabolism & Pharmacokinetics, Millennium Pharmaceuticals, Inc., A Wholly Owned Subsidiary of Takeda Pharmaceutical Company Limited, 40 Landsdowne Street, Cambridge, MA 02139, USA.

Publisher: Taylor & Francis Country of Publication: England NLM ID: 101512484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-6199 (Electronic) Linking ISSN: 17576180 NLM ISO Abbreviation: Bioanalysis Subsets: MEDLINE

Gao L; Drug Metabolism Department, Merck Research Laboratories, Kenilworth, New Jersey 07033, United States. lan.gao@merck.com; Li J; Kasserra C; Song Q; Arjomand A; Hesk D; Chowdhury SK

Publisher: American Chemical Society Country of Publication: United States NLM ID: 0370536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6882 (Electronic) Linking ISSN: 00032700 NLM ISO Abbreviation: Anal Chem Subsets: MEDLINE

Ma S; Merck Research Laboratories, Kenilworth, NJ 07033, USA.; Chowdhury SK

Publisher: American Chemical Society Country of Publication: United States NLM ID: 0370536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6882 (Electronic) Linking ISSN: 00032700 NLM ISO Abbreviation: Anal Chem Subsets: MEDLINE